Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation: Data from the Fabry Outcome Survey

Later Onset Fabry Disease, Cardiac Damage Progress in Silence

(2016) Ting-Rong Hsu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fabry disease and the heart

(2015) Nora Seydelmann et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Endomyocardial biopsy in Anderson–Fabry disease: The key in uncertain cases

(2015) C. Tschöpe et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

(2015) Dominique P Germain et al.   JOURNAL OF MEDICAL GENETICS

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

(2015) Marieke Biegstraaten et al.   Orphanet Journal of Rare Diseases

Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4 + 919G > A)

(2014) Ting-Rong Hsu et al.   Orphanet Journal of Rare Diseases

Echocardiographic Assessment of Fabry Cardiomyopathy: Early Diagnosis and Follow-Up

(2011) Maurizio Pieroni   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Therapeutic goals in the treatment of Fabry disease

(2010) Atul Mehta et al.   GENETICS IN MEDICINE

Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy

(2009) Frank Weidemann et al.   CIRCULATION

Cardiac Microvascular Pathology in Fabry Disease

(2009) Beth L. Thurberg et al.   CIRCULATION

High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population

(2009) Hsiang-Yu Lin et al.   Circulation-Cardiovascular Genetics

Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A)

(2009) Wuh-Liang Hwu et al.   HUMAN MUTATION